Aptus Pharma approval is a significant step as BSE grants in-principle backing for ₹44.78 crore preferential issue.
Tag: stock market
Amneal Pharmaceuticals stock: Is it the Best Investment Now?
Amneal Pharmaceuticals stock is gaining attention after FDA approval. Discover why it’s worth considering for your portfolio.
AstraZeneca stock gains: Proven boost from FDA approval
AstraZeneca stock gains following FDA breast cancer approval and positive analyst support, signaling a promising future for investors.
